Skip to main content
. 2022 Mar 11;9:831382. doi: 10.3389/fmolb.2022.831382

FIGURE 1.

FIGURE 1

Prevalence of KRAS mutations and KRAS G12C in different systems and subtypes of rare tumors. Cancer of unknown primary, CUP; sarcomatoid carcinoma of the lung, SARCL; clear cell ovarian cancer, CCOV; neuroendocrine tumors, NETs; gastrointestinal stromal tumor, GIST.